Sue Naim

Vice President Clinical Operations and Clinical Outsourcing at ALX Oncology - Burlingame, California, United States

Sue Naim's Colleagues at ALX Oncology
Philip Fanning

Senior Director, Clinical Science

Contact Philip Fanning

Shelly Wong-Pinto

VP, Finance & Chief Accounting Officer

Contact Shelly Wong-Pinto

Marija Vrljic

Vice President Antibody Technologies

Contact Marija Vrljic

Bilqees Akhtar

Senior Director, Regulatory Affairs, Oncology

Contact Bilqees Akhtar

Mary Liu

Executive Director, Regulatory Affairs

Contact Mary Liu

View All Sue Naim's Colleagues
Sue Naim's Contact Details
HQ
["(353) 161-8000"]
Location
Alamo,California,United States
Company
ALX Oncology
Sue Naim's Company Details
ALX Oncology logo, ALX Oncology contact details

ALX Oncology

Burlingame, California, United States • 11 - 50 Employees
Biotechnology

ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. ALX Oncology's lead product candidate, evorpacept (also known as ALX148), is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated, proprietary Fc domain. Evorpacept has demonstrated promising clinical responses across a range of hematologic and solid malignancies in combination with a number of leading anti-cancer agents.

Details about ALX Oncology
Frequently Asked Questions about Sue Naim
Sue Naim currently works for ALX Oncology.
Sue Naim's role at ALX Oncology is Vice President Clinical Operations and Clinical Outsourcing.
Sue Naim's email address is ***@alxoncology.com. To view Sue Naim's full email address, please signup to ConnectPlex.
Sue Naim works in the Research industry.
Sue Naim's colleagues at ALX Oncology are Itziar Canamasas, Philip Fanning, Shelly Wong-Pinto, Marija Vrljic, Emma Sangalang, Bilqees Akhtar, Mary Liu and others.
Sue Naim's phone number is ["(353) 161-8000"]
See more information about Sue Naim